Literature DB >> 20592732

Excitement grows for potential revolution in hepatitis C virus treatment.

Alisa Opar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592732     DOI: 10.1038/nrd3214

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

Review 1.  Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Nathan Ford; Catherine Kirby; Kasha Singh; Edward J Mills; Graham Cooke; Adeeba Kamarulzaman; Philipp duCros
Journal:  Bull World Health Organ       Date:  2012-02-03       Impact factor: 9.408

Review 2.  New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.

Authors:  Jing Tong; You-wei Wang; Yuan-an Lu
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

3.  New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.

Authors:  Josep Quer; Maria Buti; Maria Cubero; Jaume Guardia; Rafael Esteban; Juan Ignacio Esteban
Journal:  Infect Drug Resist       Date:  2010-11-23       Impact factor: 4.003

4.  Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B.

Authors:  Megan H Powdrill; Jean A Bernatchez; Matthias Götte
Journal:  Viruses       Date:  2010-09-28       Impact factor: 5.818

Review 5.  Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship.

Authors:  Mahmoud M Bahgat
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

Review 6.  Analysis of Clinical Trials of New Drugs for Liver Diseases in China.

Authors:  Longfei Lin; Hui Li
Journal:  Drug Des Devel Ther       Date:  2021-07-20       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.